Although there are some reports on the prognosis and Alb of IBD treatment using anti-TNFα antibody preparations, Tighe et al. showed no significant difference between failure and non-failure Alb levels at the time of induction [23]. This evidence concerns the gene ALB and inflammatory bowel disease.